MCGRATH YVONNE (VP, Research and Development) received a stock award from ITEOS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0000950170-25-037513
Officer· VP, Research and Development
Since Jul 2020
+106.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
106.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.30K
Price / share
—
Trade value
—
% of position
49.4%
3/7/2025
31K→46.30K
Total
Net shares
+15.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | A · Award | +15.30K | — | — | 49.4% | 31K | 46.30K |
| Total | +15.30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
91K shares
Shares
+91K
Strike price
7.05
Held after
91K
Exercisable
—
3/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock91K shares | 3/7/2025 | A · Award | +91K | 7.05 | — | 91K |